Home Monitoring in Maryland

Welldoc is a digital health platform company specializing in AI-driven chronic disease management, with a focus on diabetes, hypertension, heart failure, obesity, and behavioral health. Founded in 2005 by an endocrinologist, Welldoc delivers clinically-validated, evidence-based solutions that integrate personalized, real-time insights into patient workflows. The flagship product, BlueStar® (FDA-cleared prescription digital therapeutic), provides automated patient coaching and real-time guidance for adults with type 2 diabetes. Welldoc's platform enables "care anywhere" delivery models for health plans, healthcare systems, and employers, integrating disparate health data into actionable clinical insights across the cardiometabolic spectrum. The company collaborates with major partners including Abbott, CVS Health, Eli Lilly, Dexcom, and others, leveraging data science and behavioral algorithms to improve medication adherence, lifestyle change, and self-management outcomes.

Aromha Inc develops and commercializes the Aromha Brain Health Test, a non-invasive, at-home olfactory screening tool designed for early detection of cognitive decline and neurodegenerative diseases, particularly Alzheimer's Disease and related dementias. The test was developed by Dr. Mark Albers, an Assistant Professor of Neurology at Harvard Medical School and Massachusetts General Hospital, and leverages research showing that olfactory dysfunction correlates with Alzheimer's Disease pathology years before symptom onset. The assessment consists of a simple smell test coupled with a user-friendly web-based application that delivers personalized insights and recommendations. The company targets individuals concerned about memory loss, cognitive decline, or family history of dementia, positioning early detection as enabling informed clinical decision-making, lifestyle interventions (exercise, sleep, diet), participation in early-stage clinical trials, and proactive life planning. The test is marketed directly to consumers and has received significant media coverage from news outlets including NBC Boston, WCVB, and NewsNation. The company is based in the Washington, DC metropolitan area and focuses on democratizing access to cognitive health screening outside traditional clinical settings.

PediaMetrix is a healthcare technology company specializing in AI and computer vision solutions for pediatric care. The company's flagship product, SoftSpot™, is the first and only FDA-cleared mobile application for point-of-care measurements of infant head deformity conditions, including positional plagiocephaly and other cranial abnormalities. SoftSpot enables both pediatric providers and parents to perform quantitative, repeatable head shape assessments using smartphone-based computer vision technology, supporting early detection and monitoring in clinical and home environments. The platform is designed for telemedicine and in-office use, with results interpreted by qualified healthcare professionals. PediaMetrix also offers Tummy Time Tools to support infant developmental activities. The company's mission is to make advanced measurement technology accessible to improve patient outcomes and reduce costs in pediatric healthcare delivery while maintaining robust data security through encryption systems.

SCI Medic, Inc. is a B2B supplier of home diagnostics and consumer health products serving the USA and Canada. The company specializes in developing and supplying affordable, quality medical devices and health products through both private label and control-branded programs. SCI Medic serves multiple channels including consumers, resellers, distributors, and healthcare facilities, offering products designed for personal health management and institutional procurement. The company emphasizes cost-effectiveness and reliability, supporting healthcare providers with product solutions while enabling retailers and resellers to build branded portfolios with improved margins.

Aidar Health designs and develops clinically validated digital medicine software platforms and breath- and saliva-based biosensors for precision disease management across therapeutic areas including respiratory, renal, infectious, cardiovascular, and oncology. The company operates three primary product lines: Aidar Connect (clinician web application for remote patient monitoring and care coordination), MouthLab (medical device for biosensor data collection), and Aidar Care (patient mobile application). Aidar serves multiple market segments through specialized service offerings: Long-Term Care (remote physiological monitoring, chronic care management, transitional care management, hospital-at-home programs); Life Sciences (digital biomarkers, digital companions, decentralized clinical trials, real-world evidence collection); and Population Health Management for payers. The platform enables objective, non-invasive assessment of clinical status, facilitates early disease detection, supports treatment optimization, and enables risk stratification to reduce readmissions and emergency department utilization. Aidar has received FDA clearance for its breath-based medical device and maintains partnerships with major research institutions (NIH, Johns Hopkins, VA) and government agencies (BARDA, NSF). The company targets clinical outcomes improvement and cost reduction through digital-first precision medicine approaches suitable for aging populations and chronic disease management.

EpiWatch is an FDA-cleared, prescription-based mobile health platform that delivers real-time tonic-clonic seizure detection and alerting via Apple Watch and iPhone. The AI-powered application runs passively on wearable devices to monitor seizure activity and provides immediate alerts to caregivers when critical events occur, enabling rapid intervention and reducing the risk of Sudden Unexpected Nocturnal Death in Epilepsy (SUDEP). Designed for both pediatric and adult patients with epilepsy, EpiWatch integrates with family sharing and caregiver contact systems, requiring cellular or Wi-Fi connectivity for continuous monitoring. Available by prescription only in the United States at a monthly subscription fee, the platform empowers patients with independence while providing caregivers actionable intelligence during life-threatening events.

Trinity Sterile, Inc. is a certified Minority Business Enterprise (MBE) founded in 2004 and based in Salisbury, Maryland, specializing in the manufacture and assembly of sterile medical kits, procedure trays, and disposable/reusable medical supplies for the healthcare industry. The company operates with approximately 110 employees and reported revenue of $27.6 million, establishing itself as one of the fastest-growing MBEs. Trinity Sterile manufactures surgical instruments, phlebotomy tourniquets, IV start kits, incontinence care products, and the Esmark Sterile Bandage line for wound care applications. The facility employs ethylene oxide (EtO) sterilization to ensure high safety and quality standards. The company offers custom medical kit solutions designed to streamline healthcare workflows, reduce operational costs, and enhance care delivery across diverse healthcare settings ranging from large hospital systems to specialized clinics. Trinity Sterile is ISO 13485:2016 certified and brings over 70 years of certified quality experience to its product offerings.